Maxin Company – Beijing Technology Group Technical Symposium

In the golden October, with osmanthus fragrance in the air. By the Wulong River, Fuzhou Maixin Biotechnology Development Co., Ltd. welcomed a delegation from the Beijing Pathology Technology Group to jointly carry out the “Beijing Pathology Technology Group – Maixin Company Symposium“. The visiting delegation received high attention and warm reception from our company’s leaders wherever they went. Guided by the staff, they visited our production workshop and laboratory to learn about the product production and experimental processes, as well as quality control management procedures, and expressed affirmation of our company’s production, experimental, and R&D capabilities. The “Beijing Technology Group – Maixin Company Technical Symposium” was grandly held in the conference hall on the 2nd floor of the company building, attended by our company’s leaders and heads of various departments. At the meeting, General Manager Wang first extended a heartfelt welcome to the teachers who had come from afar, and poetically introduced the long-standing and splendid Min culture to the teachers. Regarding “Maixin’s Past, Present, and Future,” he presented Maixin’s corporate culture and development history to the group, recounted a series of achievements created through meticulousness and focus, and reported on the company’s recent development trends, future corporate development prospects, and plans for the industrial park. In addition, Yang Qinghai from the R&D department and Wu Yinjian from the Quality Management department provided detailed introductions on the research and development, registration, production, and quality control of Maixin reagents.

Wang Wei, Deputy Leader and Secretary-General of the Beijing Pathology Technology Group, introduced the group’s work over the past decade to everyone, elaborated on the current status of pathology department construction and the existing problems and solutions in its development, emphasized the significance of establishing rules and regulations, training, and exchanges, shared and exchanged experiences and methods for inter-regional immunohistochemistry quality control, and jointly promoted the standardization and normalization of pathology department work.

Song Xin, Leader of the Immunohistochemistry Group of the Beijing Technology Group, delivered an excellent report focusing on immunohistochemistry work, showcasing the achievements made by the Beijing Pathology Technology Group over the years through organizing various theoretical lectures and inter-laboratory quality assessments. At the same time, she outlined future prospects for immunohistochemistry work, hoping to collaborate with pathology enterprises to promote the introduction and presentation of new antibodies, instrument demonstrations, introduction of disciplinary progress, interpretation of standards and norms, and tracking of international development trends. By leveraging the strengths of both parties, cooperation will be strengthened to jointly advance the construction and development of the pathology discipline.

With the purpose of mutual learning, exchange, common improvement, and seeking cooperation, the participants combined theory with practice, discussed problems, deliberated on development, sought breakthroughs, and expressed their views freely. The meeting concluded after five hours of exchange in a rigorous, enthusiastic, and harmonious atmosphere.

Figure 1. Maixin’s 20-year establishment is a microcosm of the development of domestic pathology enterprises. The picture shows the technical group visiting Maixin Company’s exhibition hall.

Figure 2. Visiting Maixin’s corporate culture. The picture shows the staircase “Harmonious June 1, Happy Family” parent-child activity painting competition works corridor.

Figure 6. Scene of the Beijing Technology Group – Maixin Company Technical Symposium.